A review on the lncRNA-miRNA-mRNA regulatory networks involved in inflammatory processes in Alzheimer’s disease
- 23 March 2025
- journal article
- review article
- Published by Elsevier in Brain Research
- Vol. 1856, 149595
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Long noncoding RNA MALAT1; A novel and potential therapeutic target for Alzheimer’s diseaseAlzheimer's & Dementia, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- 2021 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2021
- The clinical value of lncRNA MALAT1 and its targets miR‐125b, miR‐133, miR‐146a, and miR‐203 for predicting disease progression in chronic obstructive pulmonary disease patientsJournal of Clinical Laboratory Analysis, 2020
- Silencing of long noncoding RNA XIST attenuated Alzheimer's disease‐related BACE1 alteration through miR‐124Cell Biology International, 2019
- Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathwayJournal of Cellular Biochemistry, 2019
- High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitroJournal of Cellular Biochemistry, 2019
- MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease2017
- Hepatic mitochondrial DNA/Toll‐like receptor 9/MicroRNA‐223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in miceHepatology, 2017
- MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathwayHepatology, 2013